Skip to content

Effect of agnikarma and nirgundyadi upanaha along with shephalika kwatha in the managament of greevasandhigata vata wsr to cervical spondylosis.

A comparative clinical study on agnikarma and nirgundyadi upanaha along with shephalika kwatha in the managament of greevasandhigata vata wsr to cervical spondylosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047726
Enrollment
30
Registered
2022-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurveda college Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from greevasandhigata (cervical spondylosis) vata irrespective of demographic data. Agnikarma yogya patients as per ayurveda classics.

Exclusion criteria

Exclusion criteria: 1. Patients of uncontrolled diabetes mellitus and R.A. (Rheumatoid arthritis) positive. 2. T.B. of cervical spine &Malignancy 3. Fracture related to cervical spine 4. Other diseases like paralysis, Parkinsonâ??s disease, severe anaemia, malignancy. 5. Patients below 30 years and above 70 years. 6. Pregnancy 7. Heart disease (IHD, CCF) 8. Agnikarma ayogya patients as per classics

Design outcomes

Primary

MeasureTime frame
reduction in sign and symptoms of greevasandhigata vata w.s.r.to cervical spondylosis pain in neck stiffness in neck pain on movement of neck Timepoint: 4 weeks

Secondary

MeasureTime frame
reduction in sign and symptoms of greevasandhigata vata w.s.r.to cervical spondylosis pain in neck stiffness in neck pain on movement of neckTimepoint: 1 week,2 week, 3 week

Countries

India

Contacts

Public ContactDr Mukesh Kumar Meena

Madan Mohan Malviya Govt. Ayurved College Udaipur

drmtatu@yahoo.co.in9602800107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026